首页 > 最新文献

Gynecologic oncology最新文献

英文 中文
Early detection of uterine corpus endometrial carcinoma utilizing plasma cell-free DNA fragmentomics 利用无血浆细胞 DNA 片段组学早期检测子宫内膜癌
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.053
{"title":"Early detection of uterine corpus endometrial carcinoma utilizing plasma cell-free DNA fragmentomics","authors":"","doi":"10.1016/j.ygyno.2024.07.053","DOIUrl":"10.1016/j.ygyno.2024.07.053","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer 在肥胖驱动的子宫内膜癌临床前模型中将替扎帕肽作为一种创新治疗策略
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.032
{"title":"Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer","authors":"","doi":"10.1016/j.ygyno.2024.07.032","DOIUrl":"10.1016/j.ygyno.2024.07.032","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study Pembrolizumab 联合化放疗治疗高风险局部晚期宫颈癌:随机、双盲、III 期 ENGOT-cx11/GOG-3047/KEYNOTE-A18 研究
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.019
{"title":"Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study","authors":"","doi":"10.1016/j.ygyno.2024.07.019","DOIUrl":"10.1016/j.ygyno.2024.07.019","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overall survival among patients in GOG-0258 by molecular classification with a modified ProMisE algorithm: Ancillary analysis of GOG-0258 用改良的 ProMisE 算法对 GOG-0258 患者进行分子分类后的总生存率:GOG-0258的辅助分析
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.095
{"title":"Overall survival among patients in GOG-0258 by molecular classification with a modified ProMisE algorithm: Ancillary analysis of GOG-0258","authors":"","doi":"10.1016/j.ygyno.2024.07.095","DOIUrl":"10.1016/j.ygyno.2024.07.095","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142421036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overall survival following interval complete gross resection of advanced ovarian cancer via laparoscopy versus open surgery: Analysis of the National Cancer Database 通过腹腔镜与开腹手术对晚期卵巢癌进行间隔性完全大体切除术后的总生存率:国家癌症数据库分析
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.049
{"title":"Overall survival following interval complete gross resection of advanced ovarian cancer via laparoscopy versus open surgery: Analysis of the National Cancer Database","authors":"","doi":"10.1016/j.ygyno.2024.07.049","DOIUrl":"10.1016/j.ygyno.2024.07.049","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142421344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
APL-1702 long-term efficacy and safety for cervical histologic, high-grade squamous intraepithelial lesions: Results from a randomized, phase III, global study APL-1702 治疗宫颈组织学高级别鳞状上皮内病变的长期有效性和安全性:一项随机、III 期、全球性研究的结果
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.090
{"title":"APL-1702 long-term efficacy and safety for cervical histologic, high-grade squamous intraepithelial lesions: Results from a randomized, phase III, global study","authors":"","doi":"10.1016/j.ygyno.2024.07.090","DOIUrl":"10.1016/j.ygyno.2024.07.090","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142421024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating tumor-specific HPV DNA is a sensitive and specific biomarker for the surveillance of invasive cervical carcinoma 循环肿瘤特异性 HPV DNA 是监测浸润性宫颈癌的灵敏而特异的生物标记物
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.052
{"title":"Circulating tumor-specific HPV DNA is a sensitive and specific biomarker for the surveillance of invasive cervical carcinoma","authors":"","doi":"10.1016/j.ygyno.2024.07.052","DOIUrl":"10.1016/j.ygyno.2024.07.052","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial transcriptomics identifies unique loss of immunosurveillance in endometrial cancers of women with severe obesity 空间转录组学发现重度肥胖妇女的子宫内膜癌丧失了独特的免疫监视功能
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.031
{"title":"Spatial transcriptomics identifies unique loss of immunosurveillance in endometrial cancers of women with severe obesity","authors":"","doi":"10.1016/j.ygyno.2024.07.031","DOIUrl":"10.1016/j.ygyno.2024.07.031","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic vaccination for the elimination of HPV16+ high-grade dysplasia: A phase I clinical trial of the DNA vaccine pNGVL4aCRTE6E7L2, administered via the TriGrid™ electroporation device 消除 HPV16+ 高级发育不良的治疗性疫苗接种:通过 TriGrid™ 电穿孔设备接种 DNA 疫苗 pNGVL4aCRTE6E7L2 的 I 期临床试验
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.011
{"title":"Therapeutic vaccination for the elimination of HPV16+ high-grade dysplasia: A phase I clinical trial of the DNA vaccine pNGVL4aCRTE6E7L2, administered via the TriGrid™ electroporation device","authors":"","doi":"10.1016/j.ygyno.2024.07.011","DOIUrl":"10.1016/j.ygyno.2024.07.011","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-clinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition for low-grade serous ovarian cancer RAF/MEK钳夹阿武托米尼联合FAK抑制剂治疗低级别浆液性卵巢癌的临床前疗效
IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.ygyno.2024.07.058
{"title":"Pre-clinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition for low-grade serous ovarian cancer","authors":"","doi":"10.1016/j.ygyno.2024.07.058","DOIUrl":"10.1016/j.ygyno.2024.07.058","url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142421135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologic oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1